TSHA — Taysha Gene Therapies Inc. price, chart and key statistics

Price data

Price

$4.11

YTD price return

-25.27%

YTD total return

-25.27%

Next earnings

Nov 3, 2026

Market cap

1.3B2020-09 845.9M2026-10 1.3B+58.3% over the window

Enterprise value

940.5M

Shares outstanding

325.8M2020-09 37.8M2026-06 325.8M+762.9% over the window

52W low

$3.46

52W high

$7.30

From 52W high

-43.70%

From 52W low

+18.96%

52W range

17%

Volume

Rel volume

1.90×

30D volume

4.6M

30D $ vol

21.3M

Fundamentals

Sales (ttm)

5.5M2022-12 2.5M2026-06 5.5M+119.2% over the window

Sales/share

$0.022022-12 $0.042026-06 $0.02-57.3% over the window

EPS (ttm)

-$0.412021-12 -$4.642026-06 -$0.41-91.1% over the window

FCF (ttm)

-132.6M2021-12 -132.3M2026-06 -132.6M+0.2% over the window

FCF/share

-$0.412021-12 -$3.442026-06 -$0.41-88.2% over the window

Book value/share

$1.192020-09 $7.092026-06 $1.19-83.2% over the window

Net margin

-2728.04%2022-12 -6635.3%2026-06 -2728.0%-58.9% over the window

ROE

-38.64%2021-12 -183.0%2026-06 -38.6%-78.9% over the window

ROA

-31.81%2021-12 -81.6%2026-06 -31.8%-61.0% over the window

Debt / equity

0.13×2021-09 0.202026-06 0.13-35.8% over the window

Current ratio

17.762020-09 24.022026-06 17.76-26.1% over the window

Growth (CAGR, ttm) · 10Y

Sales

-32.29%2025-06-30 → 2026-06-308.1M → 5.5M (-32.3% total)+25.17%2022-12-31 → 2026-06-302.5M → 5.5M (+119.2% total)n/an/a

Shares

+19.46%2025-06-30 → 2026-06-30272.8M → 325.8M (+19.4% total)+71.59%2023-06-30 → 2026-06-3064.5M → 325.8M (+405.4% total)+53.38%2021-06-30 → 2026-06-3038.4M → 325.8M (+748.7% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-43.31%2025-06-30 → 2026-06-30$0.03 → $0.02 (-43.3% total)-21.60%2022-12-31 → 2026-06-30$0.04 → $0.02 (-57.3% total)n/an/a

Book value/share

+30.38%2025-06-30 → 2026-06-30$0.91 → $1.19 (+30.4% total)n/a-24.54%2021-06-30 → 2026-06-30$4.86 → $1.19 (-75.5% total)n/a

Price

-12.93%2025-10-20 → 2026-10-20$4.72 → $4.11 (-12.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.49%2023-10-20 → 2026-10-20$2.13 → $4.11 (+93.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-24.78%2021-10-20 → 2026-10-20$17.06 → $4.11 (-75.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-12.93%2025-10-20 → 2026-10-20$4.72 → $4.11 (-12.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.49%2023-10-20 → 2026-10-20$2.13 → $4.11 (+93.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-24.78%2021-10-20 → 2026-10-20$17.06 → $4.11 (-75.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-9.9×2021-12 -2.572026-10 -8.95+248.5% over the window

Fwd P/E

-8.9×

P/S (ttm)Market cap ÷ TTM revenue.

244.2×2023-03 20.472026-10 244.15+1092.8% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.5×2020-09 3.162026-10 3.46+9.4% over the window

EV/Sales (ttm)

171.5×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-9.90%2021-12 -29.5%2026-06 -6.0%-79.8% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 325.8M ÷ 272.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-19.46%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-19.46%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($630.2M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-19.46%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2021-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.3B). Same caveat as the cash buyback yield.

0.00%2021-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S

89th

P/B

19th